137 related articles for article (PubMed ID: 36650712)
1. Subtyping of hepatocellular adenomas using Gd-EOB-DTPA: a qualitative and quantitative analysis.
Schaible J; Schreyer AG; Mehrabi A; Longerich T; Kieser M; Kreimeyer S; Klauss M; Grenacher L
Acta Radiol; 2023 Jul; 64(7):2253-2260. PubMed ID: 36650712
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular adenomas: is there additional value in using Gd-EOB-enhanced MRI for subtype differentiation?
Auer TA; Fehrenbach U; Grieser C; Penzkofer T; Geisel D; Schmelzle M; Müller T; Bläker H; Seehofer D; Denecke T
Eur Radiol; 2020 Jun; 30(6):3497-3506. PubMed ID: 32086574
[TBL] [Abstract][Full Text] [Related]
3. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Vanhooymissen IJSML; Thomeer MG; Braun LMM; Gest B; van Koeverden S; Willemssen FE; Hunink M; De Man RA; Ijzermans JN; Dwarkasing RS
J Magn Reson Imaging; 2019 Mar; 49(3):700-710. PubMed ID: 30252977
[TBL] [Abstract][Full Text] [Related]
4. Qualitative and Quantitative Gadoxetic Acid-enhanced MR Imaging Helps Subtype Hepatocellular Adenomas.
Tse JR; Naini BV; Lu DS; Raman SS
Radiology; 2016 Apr; 279(1):118-27. PubMed ID: 26505921
[TBL] [Abstract][Full Text] [Related]
5. HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.
Auer TA; Walter-Rittel T; Geisel D; Schöning W; Schmelzle M; Müller T; Sinn B; Denecke T; Hamm B; Fehrenbach U
BMC Med Imaging; 2021 Feb; 21(1):28. PubMed ID: 33588783
[TBL] [Abstract][Full Text] [Related]
6. Imaging Features of Hepatocellular Carcinoma: Quantitative and Qualitative Comparison Between MRI-Enhanced With Gd-EOB-DTPA and Gd-DTPA.
Son J; Hwang SH; Park S; Han K; Chung YE; Choi JY; Kim MJ; Park MS
Invest Radiol; 2019 Aug; 54(8):494-499. PubMed ID: 31094878
[TBL] [Abstract][Full Text] [Related]
7. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.
Saito K; Kotake F; Ito N; Ozuki T; Mikami R; Abe K; Shimazaki Y
Magn Reson Med Sci; 2005; 4(1):1-9. PubMed ID: 16127248
[TBL] [Abstract][Full Text] [Related]
8. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
[TBL] [Abstract][Full Text] [Related]
9. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
10. Different signal intensity at Gd-EOB-DTPA compared with Gd-DTPA-enhanced MRI in hepatocellular carcinoma transgenic mouse model in delayed phase hepatobiliary imaging.
Korkusuz H; Knau LL; Kromen W; Bihrer V; Keese D; Piiper A; Vogl TJ
J Magn Reson Imaging; 2012 Jun; 35(6):1397-402. PubMed ID: 22267126
[TBL] [Abstract][Full Text] [Related]
11. Enhancement pattern of hepatocellular adenoma (HCA) on MR imaging performed with Gd-EOB-DTPA versus other Gd-based contrast agents (GBCAs): An intraindividual comparison.
Cannella R; Brancatelli G; Rangaswamy B; Minervini MI; Borhani AA; Furlan A
Eur J Radiol; 2019 Oct; 119():108633. PubMed ID: 31437747
[TBL] [Abstract][Full Text] [Related]
12. OATPB1/B3 and MRP3 expression in hepatocellular adenoma predicts Gd-EOB-DTPA uptake and correlates with risk of malignancy.
Sciarra A; Schmidt S; Pellegrinelli A; Maggioni M; Dondossola D; Pasquier J; Cigala C; Tosi D; Halkic N; Bulfamante G; Viale G; Bosari S; Balabaud C; Bioulac-Sage P; Sempoux C
Liver Int; 2019 Jan; 39(1):158-167. PubMed ID: 30218633
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of enhancement patterns in focal solid liver lesions with Gd-EOB-DTPA-enhanced MRI.
Haimerl M; Wächtler M; Zeman F; Verloh N; Platzek I; Schreyer AG; Stroszczynski C; Wiggermann P
PLoS One; 2014; 9(6):e100315. PubMed ID: 24950259
[TBL] [Abstract][Full Text] [Related]
15. Gd-EOB-DTPA-enhanced magnetic resonance imaging features of hepatic hemangioma compared with enhanced computed tomography.
Tateyama A; Fukukura Y; Takumi K; Shindo T; Kumagae Y; Kamimura K; Nakajo M
World J Gastroenterol; 2012 Nov; 18(43):6269-76. PubMed ID: 23180948
[TBL] [Abstract][Full Text] [Related]
16. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
[TBL] [Abstract][Full Text] [Related]
17. Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production.
Asayama Y; Tajima T; Nishie A; Ishigami K; Kakihara D; Nakayama T; Okamoto D; Fujita N; Aishima S; Shirabe K; Honda H
Eur J Radiol; 2011 Dec; 80(3):e243-8. PubMed ID: 21109378
[TBL] [Abstract][Full Text] [Related]
18. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.
Reizine E; Ronot M; Ghosn M; Calderaro J; Frulio N; Bioulac-Sage P; Trillaud H; Vilgrain V; Paradis V; Luciani A
Eur Radiol; 2021 May; 31(5):3417-3426. PubMed ID: 33146794
[TBL] [Abstract][Full Text] [Related]
19. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
Chen CY; Chen J; Xia CC; Huang ZX; Song B
J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of combined Gd-EOB-DTPA and gadobutrol magnetic resonance imaging for the prediction of hepatocellular carcinoma grading.
Schelhorn J; Best J; Dechêne A; Göbel T; Bertram S; Lauenstein T; Kinner S
Acta Radiol; 2016 Aug; 57(8):932-8. PubMed ID: 26586852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
